Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

Jesus Anampa; Tamanna Haque; Irina Murakhovskaya; Yanhua Wang; Kimo Bachiashvili; Cristian Papazoglu; Kith Pradhan; Ulrich G. Steidl; Joseph A. Sparano; Amit Verma

doi:10.3324/haematol.2017.181941

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

Jesus Anampa, Tamanna Haque, Irina Murakhovskaya, Yanhua Wang, Kimo Bachiashvili, Cristian Papazoglu, Kith Pradhan, Ulrich G. Steidl, Joseph A. Sparano, Amit Verma

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	e98-e102
Journal	Haematologica
Volume	103
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2017.181941
State	Published - Feb 28 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2017.181941

Cite this

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer. / Anampa, Jesus; Haque, Tamanna; Murakhovskaya, Irina; Wang, Yanhua; Bachiashvili, Kimo; Papazoglu, Cristian; Pradhan, Kith ; Steidl, Ulrich G.; Sparano, Joseph A.; Verma, Amit.

In: Haematologica, Vol. 103, No. 3, 28.02.2018, p. e98-e102.

Research output: Contribution to journal › Letter › peer-review

Anampa, Jesus ; Haque, Tamanna ; Murakhovskaya, Irina ; Wang, Yanhua ; Bachiashvili, Kimo ; Papazoglu, Cristian ; Pradhan, Kith ; Steidl, Ulrich G. ; Sparano, Joseph A. ; Verma, Amit. / Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer. In: Haematologica. 2018 ; Vol. 103, No. 3. pp. e98-e102.

@article{b85dcaf8198a4f89b6f494a68f5cf25d,

title = "Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer",

author = "Jesus Anampa and Tamanna Haque and Irina Murakhovskaya and Yanhua Wang and Kimo Bachiashvili and Cristian Papazoglu and Kith Pradhan and Steidl, {Ulrich G.} and Sparano, {Joseph A.} and Amit Verma",

note = "Funding Information: 1Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center; 2Department of Oncology, Division of Hematology, Montefiore Medical Center,; 3Department of Pathology, Montefiore Medical Center; 4Department of Developmental & Molecular Biology, NY and 5Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA Correspondence: janampa@montefiore.org doi:10.3324/haematol.2017.181941 Funding: the manuscript development is supported by The Einstein Paul Calabresi Career Development Program (NIH 5K12CA132783-08) and NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA (Grant n. UL1TR001073). Funding Information: Funding: the manuscript development is supported by The Einstein Paul Calabresi Career Development Program (NIH 5K12CA132783-08) and NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA (Grant n. UL1TR001073).",

year = "2018",

month = feb,

day = "28",

doi = "10.3324/haematol.2017.181941",

language = "English (US)",

volume = "103",

pages = "e98--e102",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

TY - JOUR

T1 - Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

AU - Anampa, Jesus

AU - Haque, Tamanna

AU - Murakhovskaya, Irina

AU - Wang, Yanhua

AU - Bachiashvili, Kimo

AU - Papazoglu, Cristian

AU - Pradhan, Kith

AU - Steidl, Ulrich G.

AU - Sparano, Joseph A.

AU - Verma, Amit

N1 - Funding Information: 1Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center; 2Department of Oncology, Division of Hematology, Montefiore Medical Center,; 3Department of Pathology, Montefiore Medical Center; 4Department of Developmental & Molecular Biology, NY and 5Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA Correspondence: janampa@montefiore.org doi:10.3324/haematol.2017.181941 Funding: the manuscript development is supported by The Einstein Paul Calabresi Career Development Program (NIH 5K12CA132783-08) and NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA (Grant n. UL1TR001073). Funding Information: Funding: the manuscript development is supported by The Einstein Paul Calabresi Career Development Program (NIH 5K12CA132783-08) and NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA (Grant n. UL1TR001073).

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042632788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042632788&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.181941

DO - 10.3324/haematol.2017.181941

M3 - Letter

C2 - 29191840

AN - SCOPUS:85042632788

VL - 103

SP - e98-e102

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this